BLITZ Heart Failure

Heart Care Foundation7,569 enrolled

Overview

To evaluate if Italian Cardiologists are treating Heart Failure (HF) patients according to International guidelines and if a structured educational program can improved their adherence.

Multicentre, cross-sectional, prospective, non-interventional, observational study designed to evaluate the level of adherence to current ESC guidelines recommendations in both acute and chronic HF patients enrolled in each participating center and to verify if a specific HF educational intervention composed by an educational web based program of data collection and face to face meetings is able to improve adherence to guidelines recommendations evaluated during a second enrollment period.

Study Type

OBSERVATIONAL

Enrollment

7,569

Conditions

Heart Failure

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All consecutive patients with chronic HF and those admitted for acute (de novo) or worsening chronic HF. * Chronic HF: any NYHA class (I-IV). * Acute HF Only patients in NYHA class III or IV, or with pulmonary edema or cardiogenic shock for whom an IV therapy specific for HF (diuretic, vasodilators, vasopressors) is administered. * Any gender. * Any etiology of HF. * Any level of EF. * Written informed consent. Exclusion Criteria: * \- Age \<18 years. * Inclusion in registries or trials that can influence, by protocol, the clinical management of patients. * Patients already enrolled in the BLITZ HF (by another participating centre or in the first enrollment period).

Locations (123)

Outcomes

Primary Outcomes

Adherence to current guideline

To assess number of patients managed and treated following the 2016 ESC Heart Failure Gudelines (acute HF, chronic HFrEF, chronic HFmrEF, chronic HFpEF).

Time frame: Enrollment

Patients managed and treated following International Guideline

Patients treatment in phase 1 versus phase 3

Time frame: 24 months

Secondary Outcomes

Mortality

Death from all-causes, for cardiovascular causes, for HF

Time frame: 12 months Follow-up

Morbidity

Hospital admissions from all-causes, for cardiovascular causes, for HF

Time frame: 12 months Follow-up

Indication to heart failure device implantation

The rate of patients with chronic HFrEF with an indication to ICD and/or CRT planned in clinical practice

Time frame: Enrollement

Prescription rate of disease modifying drugs

The rate of patients with HFrEF receiving all the drugs recommended by current guidelines: ACE-Is/ARBs, betablockers and MRAs, in the absence of specific contraindications/intolerance.

Time frame: Enrollment

Oral anticoagulation prescription in patients with AF

Rate of patients treated with oral anticoagulants in case of AF

Time frame: Enrollment

Use of ARNI

The rate of implementation of a new drug approach (ARNI) for patients with HF and EF ≤35%

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Ospedali Riuniti - Sod Cardiologia Ospedaliera Emod. E Utic

Ancona, AN, Italy

Ospedale Generale Regionale-Po U. Parini - U.O. Cardiologia E Cure Intensive Card.

Aosta, AO, Italy

Ospedale Gen.Le Prov.Le C.G. Mazzoni - Sc Cardiologia

Ascoli Piceno, AP, Italy

Ospedale Valdichiana Santa Margherita - Uos Cardiologia E Hdu

Cortona, AR, Italy

Aorn San Giuseppe Moscati - U.O. Cardiologia/Utic 'D. Rotiroti'

Avellino, AV, Italy

Asst Papa Giovanni Xxiii - Cardiologia 1

Bergamo, BG, Italy

Ospedale Bolognini - Cardiologia E Unita' Coronarica

Seriate, BG, Italy

Ospedali Treviglio-Caravaggio - Cardiologia

Treviglio, BG, Italy

Ospedale Santa Maria Del Prato - U.O. Di Cardiologia

Feltre, BL, Italy

Ospedale Maggiore - U.O. Di Cardiologia

Bologna, BO, Italy

...and 113 more locations